Literature DB >> 19796233

Complex and context dependent regulation of hematopoiesis by TGF-beta superfamily signaling.

Sofie Singbrant Söderberg1, Göran Karlsson, Stefan Karlsson.   

Abstract

The transforming growth factor (TGF)-beta superfamily of growth factors, including the TGF-betas, activins, and bone morphogenetic proteins (BMPs), provide cells with a broad spectrum of regulatory signals through the intracellular Smad pathway. Since loss-of-function studies of a majority of the TGF-beta superfamily members result in embryonic lethality, much of our current knowledge of the TGF-beta superfamily's role in hematopoiesis is generated from studies performed in vitro, or in very early stages of embryonic development. TGF-beta is well documented as a potent inhibitor of hematopoietic stem cell (HSC) proliferation in vitro, while its role in vivo is largely unknown. BMP signaling is crucial for the initiation of hematopoiesis in the developing embryo, although its role in adult hematopoiesis remains elusive. More recently we and others have used conditional knockout models to unravel the role of several components of TGF-beta family signaling in adult hematopoiesis. Here we review the currently known functions for the major factors of this signaling family in embryonic and adult hematopoietic regulation and discuss the context dependency and complexity that permeate this regulation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19796233     DOI: 10.1111/j.1749-6632.2009.04569.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  54 in total

1.  Osteoblast proliferation and differentiation on a barrier membrane in combination with BMP2 and TGFβ1.

Authors:  Richard J Miron; Nikola Saulacic; Daniel Buser; Tateyuki Iizuka; Anton Sculean
Journal:  Clin Oral Investig       Date:  2012-06-06       Impact factor: 3.573

2.  Smad1 signaling restricts hematopoietic potential after promoting hemangioblast commitment.

Authors:  Brandoch D Cook; Susanna Liu; Todd Evans
Journal:  Blood       Date:  2011-04-22       Impact factor: 22.113

Review 3.  The aryl hydrocarbon receptor: regulation of hematopoiesis and involvement in the progression of blood diseases.

Authors:  Fanny L Casado; Kameshwar P Singh; Thomas A Gasiewicz
Journal:  Blood Cells Mol Dis       Date:  2010-02-19       Impact factor: 3.039

4.  BMP-mediated specification of the erythroid lineage suppresses endothelial development in blood island precursors.

Authors:  Candace T Myers; Paul A Krieg
Journal:  Blood       Date:  2013-10-07       Impact factor: 22.113

Review 5.  TGF-β signaling and its role in the regulation of hematopoietic stem cells.

Authors:  Anuradha Vaidya; Vaijayanti P Kale
Journal:  Syst Synth Biol       Date:  2015-01-29

6.  The kinase activity of the Ser/Thr kinase BUB1 promotes TGF-β signaling.

Authors:  Shyam Nyati; Katrina Schinske-Sebolt; Sethuramasundaram Pitchiaya; Katerina Chekhovskiy; Areeb Chator; Nauman Chaudhry; Joseph Dosch; Marcian E Van Dort; Sooryanarayana Varambally; Chandan Kumar-Sinha; Mukesh Kumar Nyati; Dipankar Ray; Nils G Walter; Hongtao Yu; Brian Dale Ross; Alnawaz Rehemtulla
Journal:  Sci Signal       Date:  2015-01-06       Impact factor: 8.192

Review 7.  Lung as a Niche for Hematopoietic Progenitors.

Authors:  Isabella Borges; Isadora Sena; Patrick Azevedo; Julia Andreotti; Viviani Almeida; Ana Paiva; Gabryella Santos; Daniel Guerra; Pedro Prazeres; Luiza Lousado Mesquita; Luanny Souto de Barros Silva; Caroline Leonel; Akiva Mintz; Alexander Birbrair
Journal:  Stem Cell Rev Rep       Date:  2017-10       Impact factor: 5.739

8.  Tumor microenvironment and myeloid-derived suppressor cells.

Authors:  Viktor Umansky; Alexandra Sevko
Journal:  Cancer Microenviron       Date:  2012-12-16

Review 9.  Dormancy in solid tumors: implications for prostate cancer.

Authors:  Nazanin S Ruppender; Colm Morrissey; Paul H Lange; Robert L Vessella
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

10.  An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia.

Authors:  Tanja A Gruber; Amanda Larson Gedman; Jinghui Zhang; Cary S Koss; Suresh Marada; Huy Q Ta; Shann-Ching Chen; Xiaoping Su; Stacey K Ogden; Jinjun Dang; Gang Wu; Vedant Gupta; Anna K Andersson; Stanley Pounds; Lei Shi; John Easton; Michael I Barbato; Heather L Mulder; Jayanthi Manne; Jianmin Wang; Michael Rusch; Swati Ranade; Ramapriya Ganti; Matthew Parker; Jing Ma; Ina Radtke; Li Ding; Giovanni Cazzaniga; Andrea Biondi; Steven M Kornblau; Farhad Ravandi; Hagop Kantarjian; Stephen D Nimer; Konstanze Döhner; Hartmut Döhner; Timothy J Ley; Paola Ballerini; Sheila Shurtleff; Daisuke Tomizawa; Souichi Adachi; Yasuhide Hayashi; Akio Tawa; Lee-Yung Shih; Der-Cherng Liang; Jeffrey E Rubnitz; Ching-Hon Pui; Elaine R Mardis; Richard K Wilson; James R Downing
Journal:  Cancer Cell       Date:  2012-11-13       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.